Sana Biotechnology, Inc. Common Stock

SANA XNAS • BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

880M

Short interest (Jul 15)

14.3%

Net Short (Jul 27 ): 0.1%

Borrow Fee

0.38%

↓ 3.1%

Available Shares

↓ 4.6%

Price Chart

Company Overview

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates comprises SC291, SC262, UP421, and others.

Company Info

Exchange: NASDAQ

Industry: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

CIK: 0001770121

Asset Type: CS

Market Data

Market Cap: $884,967,256

Employees: 142

Status: Active

Short Interest

Current Borrow Fee 0.38%

Range: 0.38% - 0.38%

Available Shares 2M

Range: 1.8M - 1.9M

Recent Changes

Fee Change: ↓ 0.0%

Available Change: ↓ 5.3%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime